Literature DB >> 95233

Central serotonin metabolism and frequency of depression.

H M van Praag, S de Haan.   

Abstract

Central serotonin (5-hydroxytryptamine; 5-HT) metabolism can be disturbed in a subgroup of patients with vital (endogenous, primary) depression. Presumably these disturbances do not result from the depression and have a predisposing rather than a causative relationship to it. This latter statement is based on two observations. First, in a majority of patients, the 5-HT disturbances persist after depression has abated. Secondly, 5-hydroxytryptophan seems to have prophylactic value, in particular in patients with persistent abnormalities in central 5-HT metabolism. In this study we approached the hypothesis that 5-HT disturbances are a predisposing factor to the occurrence of depression from still another perspective. If this hypothesis is correct, then depressive patients with persistent 5-HT disturbances should have higher frequencies of depression than depressive patients without demonstrable 5-HT disturbances. This was indeed demonstrated. The same was true for family members of probands with low levels of 5-hydroxyindoleacetic acid. No cerebrospinal fluid data are available for family members. The reported findings strongly support the predisposition hypothesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 95233     DOI: 10.1016/0165-1781(79)90002-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Platelet imipramine binding in intensive care unit suicidal patients.

Authors:  D De Leo; A Caneva; D Marazziti; L Conti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 2.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 3.  Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications.

Authors:  Anniek K D Visser; Aren van Waarde; Antoon T M Willemsen; Fokko J Bosker; Paul G M Luiten; Johan A den Boer; Ido P Kema; Rudi A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-27       Impact factor: 9.236

Review 4.  The use of diet and dietary components in the study of factors controlling affect in humans: a review.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

5.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

6.  Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.

Authors:  C M Banki; G Molnar; I Fekete
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

7.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

8.  Segregation and linkage analyses in families of patients with bipolar, unipolar, and schizoaffective mood disorders.

Authors:  L R Goldin; E S Gershon; S D Targum; R S Sparkes; M McGinniss
Journal:  Am J Hum Genet       Date:  1983-03       Impact factor: 11.025

9.  Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease.

Authors:  S J Huber; G W Paulson; E C Shuttleworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Tryptophan depletion causes a rapid lowering of mood in normal males.

Authors:  S N Young; S E Smith; R O Pihl; F R Ervin
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.